Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy in Lung Cancer: Which Treatment After Immunotherapy Cessation: A Prospective Registry From the European Lung Cancer Working Party

NCT04465942 is registered in ClinicalTrials.gov with European Lung Cancer Working Party as lead sponsor.

NCT NCT04465942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04465942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy in Lung Cancer: Which Treatment After Immunotherapy Cessation: A Prospective Registry From the European Lung Cancer Working Party
Lead sponsor
European Lung Cancer Working Party
Phase
Observational
Overall status
Unknown status
Start date
June 26, 2020
Completion date
June 30, 2025
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, immunotherapy